Holt Capital Partners’s Gilead Sciences GILD Stock Holding History

Holt Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,630	Closed	-$236K	–	142
2019 Q4	$236K	Sell	3,630 -1,345	-27%	-$87.6K	0.06%	138
2019 Q3	$315K	Sell	4,975 -420	-8%	-$27.5K	0.09%	116
2019 Q2	$364K	Sell	5,395 -45	-0.8%	-$2.96K	0.1%	114
2019 Q1	$354K	Sell	5,440 -645	-11%	-$42.9K	0.1%	112
2018 Q4	$381K	Sell	6,085 -1,360	-18%	-$95.1K	0.12%	104
2018 Q3	$575K	Sell	7,445 -180	-2%	-$13.6K	0.16%	94
2018 Q2	$540K	Sell	7,625 -55	-0.7%	-$3.88K	0.16%	96
2018 Q1	$579K	Buy	7,680 +100	+1%	+$7.95K	0.18%	89
2017 Q4	$543K	Sell	7,580 -100	-1%	-$7.59K	0.17%	92
2017 Q3	$622K	Sell	7,680 -200	-3%	-$15.3K	0.2%	80
2017 Q2	$558K	Hold	7,880	–	–	0.19%	85
2017 Q1	$535K	Buy	7,880 +360	+5%	+$25.3K	0.19%	89
2016 Q4	$539K	Sell	7,520 -560	-7%	-$41.6K	0.2%	88
2016 Q3	$639K	Buy	8,080 +170	+2%	+$13.8K	0.25%	80
2016 Q2	$660K	Buy	7,910 +165	+2%	+$14.6K	0.27%	71
2016 Q1	$711K	Hold	7,745	–	–	0.31%	65
2015 Q4	$784K	Sell	7,745 -40	-0.5%	-$4.16K	0.35%	58
2015 Q3	$764K	Buy	7,785 +20	+0.3%	+$2.22K	0.32%	57
2015 Q2	$909K	Sell	7,765 -145	-2%	-$15.8K	0.37%	56
2015 Q1	$776K	Buy	+7,910	New	+$803K	0.32%	58

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Holt Capital Partners's GILD Position: Q1 2020 in Review

Holt Capital Partners sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 3,630 shares — an estimated $236K sold.

Holt Capital Partners first reported a position in GILD in Q1 2015 and held it in 20 quarters. The position peaked at $909K in Q2 2015. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

Holt Capital Partners reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
Holt Capital Partners sold 3,630 Gilead Sciences shares in Q1 2020, an estimated $236K.
Holt Capital Partners first reported a position in Gilead Sciences in Q1 2015 and held it in 20 quarters.
Holt Capital Partners's Gilead Sciences position peaked at $909K in Q2 2015.
1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Holt Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.